Skip to main content

Day: August 21, 2020

Intercept to Present New NASH and PBC Data at the Digital International Liver Congress™ 2020

New analyses of the interim analysis data from the Phase 3 REGENERATE study describe the benefit of obeticholic acid (OCA) on noninvasive measures of liver fibrosis in NASH patients on treatment for at least 24 monthsAdditional long-term data in PBC highlight the safety and durable efficacy of OCA through six years of open label treatmentNEW YORK, Aug. 21, 2020 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that multiple abstracts regarding the treatment of primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH) with OCA will be presented at the Digital International Liver Congress™ 2020, the 55th Annual Meeting of the European Association...

Continue reading

Collectors Universe to Announce Fourth Quarter and Fiscal Year 2020 Financial Results on August 26, 2020

NEWPORT BEACH, Calif., Aug. 21, 2020 (GLOBE NEWSWIRE) — Collectors Universe, Inc. (NASDAQ: CLCT), a leading provider of value-added authentication and grading services to dealers and collectors of collectibles, will release its fourth quarter and fiscal year ended June 30, 2020, financial results on Wednesday, August 26, 2020, after market close.Collectors Universe will host a conference call to discuss the results on August 26, 2020 at 4:30 p.m. Eastern/1:30 p.m. Pacific.  Interested parties may participate in the conference call by dialing 800-437-2398 or 323-289-6576  five to ten minutes prior to the initiation of the call, using the call confirmation code of 3865933,  A replay of the conference call will be available through September 9, 2020, by dialing 888-203-1112 or 719-457-0820 and entering access code 3865933#.  A live...

Continue reading

Macarthur’s Joint Venture Partner Fe Limited Acquires Advanced Iron Ore Project

VANCOUVER, British Columbia, Aug. 21, 2020 (GLOBE NEWSWIRE) — Macarthur Minerals Limited (ASX: MIO) (TSX-V: MMS) (the “Company” or “Macarthur”) Joint Venture Partner, Fe Limited (“FEL”) has announced that it has entered into a binding Heads of Agreement to acquire a 50% interest in the Yarram Iron Ore Project in the Northern Territory.The consideration is A$1.5m in cash and shares with a further A$1.5m in cash and shares payable on achieving a JORC indicated resource milestone. FEL is to cover certain historical and future costs.  FEL will operate the Joint Venture and has a casting vote on the majority of key issues, with approval of other matters not to be unreasonably withheld.Outstanding historical drill intercepts include:108m @ 65.6% Fe, 2.3% SiO2, 1.8% Al2O3, 0.037% P from 18m in hole RJRC0119 65m @ 66.4% Fe, 2.0% SiO2, 1.5%...

Continue reading

COOPERATION NEGOTIATIONS CONCERNING ROBIT FINLAND LTD’S SENIOR SALARIED EMPLOYEES HAVE ENDED

ROBIT PLC        PRESS RELEASE        21 AUGUST 2020 AT 3.00 P.M.COOPERATION NEGOTIATIONS CONCERNING ROBIT FINLAND LTD’S SENIOR SALARIED EMPLOYEES HAVE ENDEDThe cooperation negotiations concerning Robit Finland Ltd’s senior salaried employees ended on Thursday, 20 August 2020. Robit disclosed the initiation of the cooperation negotiations with a press release on 4 August 2020.The cooperation negotiations covered all the senior salaried personnel of Robit Finland Ltd. The estimated need for reduction was five persons, at most.As a result of the cooperation negotiations, Robit decided to terminate four persons, considering the current situation and future business needs and goals. The persons subject to the redundancies have been released from their obligation to work.The object of the cooperation negotiations was to ensure and strengthen...

Continue reading

ROBIT FINLAND OY:N YLEMPIÄ TOIMIHENKILÖITÄ KOSKENEET YT-NEUVOTTELUT OVAT PÄÄTTYNEET

ROBIT OYJ        LEHDISTÖTIEDOTE        21.8.2020 KLO 15.00ROBIT FINLAND OY:N YLEMPIÄ TOIMIHENKILÖITÄ KOSKENEET YT-NEUVOTTELUT OVAT PÄÄTTYNEETRobit Finland Oy:n ylempiä toimihenkilöitä koskeneet yhteistoimintaneuvottelut päättyivät torstaina 20.8.2020. Yhtiö tiedotti neuvottelujen alkamisesta lehdistötiedotteella 4.8.2020.Neuvottelut koskivat kaikkia Robit Finland Oy:n ylempien toimihenkilöiden henkilöstöryhmään kuuluvia työntekijöitä. Arvioitu vähentämistarve oli enintään viisi henkilöä.Neuvottelujen tuloksena yhtiö päätti irtisanoa neljä henkilöä yhtiön nykytilanne sekä tulevaisuuden liiketoiminnan tarpeet ja tavoitteet huomioiden. Irtisanomisten kohteena olevat henkilöt on vapautettu työvelvoitteistaan.Yhteistoimintaneuvottelujen tarkoituksena oli yrityksen kannattavuuden sekä kassavirran varmistaminen ja vahvistaminen pitkällä aikavälillä.ROBIT...

Continue reading

Red White & Bloom Brands Inc. Announces Upsized $25 Million Bought Deal Public Offering Inclusive of Full Exercise of Over-Allotment Option

TORONTO, Aug. 21, 2020 (GLOBE NEWSWIRE) — Red White and Bloom Brands Inc. (CSE: RWB and OTC:RWBYF) (“RWB” or the “Company“) is pleased to announce that, in connection with its previously announced bought deal offering, RWB and a syndicate of underwriters, co-led by PI Financial Corp. and Eight Capital (collectively the “Underwriters“), have agreed to increase the size of the offering. The Underwriters will now place, on an underwritten bought deal basis, 29,000,000 units of the RWB (the “Units“) at an issue price of $0.75 per Unit (the “Offering Price“) for aggregate gross proceeds of $21.75 million (the “Offering“). In connection with Offering, the Company has granted the Underwriters an option, exercisable in whole or in part at any time for a period of 30 days...

Continue reading

Arch Biopartners Obtains DTC Eligibility for its Common Shares on OTCQB

TORONTO, Aug. 21, 2020 (GLOBE NEWSWIRE) — Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced it has obtained eligibility with The Depository Trust Company (DTC) in the United States, increasing access for U.S. investors for its common shares listed on the OTCQB.DTC Eligibility means Arch shares can now be transferred and settled between brokerage accounts electronically, enabling the stock to be traded over a wider network of brokerage firms by coming into compliance with their requirements.DTC is a subsidiary of the Depository Trust & Clearing Corp., a company that manages the electronic clearing and settlement of publicly traded securities in the U.S. DTC services provide cost benefits for investors and brokers trading Canadian securities in the United States.“We expect the DTC...

Continue reading

Tauriga Sciences, Inc. Showcases the Final Design of its Point of Sale Display Case for Select Retail Locations

This Display Case will be Allocated to Select, High Volume, Retail Locations in Support of Upcoming National Roll-out of Tauri-Gum™ BrandNEW YORK, NY, Aug. 21, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of functional “supplement” chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as two ongoing Biotechnology initiatives, today showcased the illustrative design of the Final version of its Point of Sale (“POS”) display case for select retail locations.  This display case will be allocated to select, high volume, retail locations in support of upcoming National Roll-Out (“National Launch”) of Tauri-Gum™ brand (expected to commence...

Continue reading

Reunion Gold Announces Application to Extend 2017 Warrants

LONGUEUIL, Quebec, Aug. 21, 2020 (GLOBE NEWSWIRE) — Reunion Gold Corporation (TSX-V: RGD) (“Reunion” or the “Company”) announces that it is applying to the TSX Venture Exchange (the “TSXV”) for approval of an extension to the term of a total of 42,082,495 share purchase warrants (the “Warrants”) originally issued as part of a non-brokered private placement completed in two tranches in September 2017. Each Warrant entitles its holder to acquire one common share of the Company at an exercise price of $0.20 per share. The Warrants were issued for a term of three years. Of the total Warrants, 39,003,595 are expiring on September 8, 2020 and 3,078,900 on September 18, 2020. The Company is seeking to extend the expiry date of all Warrants to March 31, 2021. The exercise price will remain unchanged.The proposed extension of the expiration...

Continue reading

DSS Completes Impact BioMedical Acquisition

ROCHESTER, N.Y., Aug. 21, 2020 (GLOBE NEWSWIRE) — Document Security Systems, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating businesses focusing on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, is pleased to announce the closing of the Company’s acquisition of Impact BioMedical.“We are excited to report the official closing of our Impact BioMedical acquisition,” stated Frank D. Heuszel, CEO of DSS. “This transaction is a major milestone for DSS and provides us the opportunity to follow through on our vision of sharing the economic benefits of our success with our shareholders.”The Company’s long-term plans for Impact BioMedical include taking it public through an initial public offering (“IPO”). As previously announced,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.